Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well sorafenib works in treating patients with soft
tissue sarcoma. Sorafenib may stop the growth of soft tissue sarcoma by blocking blood flow
to the tumor and blocking some of the enzymes needed for tumor cell growth